bioRxiv · 10.1101/2022.08.16.504103
Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog Pathway Inhibitor-1
Abstract
Target deconvolution of small molecule hits from phenotypic screens presents a major challenge. Illustrative of these are the many screens that have been conducted to find inhibitors for the Hedgehog (Hh) signaling pathway - a major developmental pathway with many implications in health and disease - with many hits but very few identified cellular targets. We here present a strategy for target identification based on Proteolysis-Targeting Chimeras (PROTACs), combined with label-free quantitative proteomics. We developed a PROTAC based on the downstream Hedgehog Pathway Inhibitor-1 (HPI-1), a phenotypic screen hit with unknown cellular target. Using our Hedgehog Pathway PROTAC (HPP) we identified and validated BET bromodomains to be the cellular targets of HPI-1. Furthermore, we found that HPP-9 has a unique mechanism of action as a long-acting Hh pathway inhibitor through prolonged BET bromodomain degradation. Collectively, we provide a powerful PROTAC-based approach for target deconvolution, that has answered the longstanding question of the cellular target of HPI-1 and yielded the first PROTAC that acts on the Hh pathway.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Bagka, M., Choi, H., Heritier, M., Scapozza, L., Wu, Y., Hoogendoorn, S.. 2022-08-16. Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog Pathway Inhibitor-1. https://doi.org/10.1101/2022.08.16.504103
Cite the original work for its findings. Save a collection to share your selection of sources.